This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NewLink Genetics Corp (NLNK)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 190.40M 61.29M 20.25M 39.49M
Receivables 19.33M 1.66M 738.00K 399.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 12.39M 249.00K 2.40M 2.90M
Total Current Assets 230.46M 63.97M 23.39M 42.79M
Property, Plant & Equipment, Gross 12.55M 10.45M 9.02M 8.50M
Accumulated Depreciation & Depletion 4.96M 3.86M 2.98M 2.91M
Property, Plant & Equipment, Net 7.60M 6.59M 6.04M 5.59M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 7.60M 6.59M 6.04M 5.59M
Liabilities & Shareholder Equity
Total Assets 238.06M 70.56M 29.43M 48.38M
Accounts Payable 2.41M 612.00K 972.00K 1.67M
Short Term Debt 35.00K 35.00K 204.00K 214.00K
Other Current Liabilities 84.00K 130.00K 0.00 0.00
Total Current Liabilities 25.02M 3.88M 2.92M 10.66M
Long Term Debt 941.00K 987.00K 1.14M 848.00K
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 8.32M 7.32M 1.41M 0.00
Minority Interest 0.00 0.00 0.00 -1.00K
Total Non-Current Liabilities 9.26M 8.35M 8.58M 942.00K
Total Liabilities 34.28M 12.23M 11.50M 11.61M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 203.78M 58.33M 17.93M 36.77M
Common Par 280.00K 266.00K 210.00K 206.00K
Additional Paid In Capital 236.84M 194.04M 122.51M 118.04M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -33.12M -135.98M -104.80M -81.48M
Treasury Stock -222.00K 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 204.72M 59.31M 19.07M 37.62M
Total Equity 203.78M 58.33M 17.93M 36.77M
Total Liabilities & Stock Equity 238.06M 70.56M 29.43M 48.38M
Total Common Shares Outstanding 27.98M 26.57M 20.99M 20.59M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 10.39K 0.00 0.00 0.00
Basic Weighted Shares Outstanding 27.84M 25.28M 20.78M 6.06M
Diluted Weighted Shares Outstanding 31.03M 25.28M 20.78M 6.06M
Number of Employees 130 104 94 77
Number of Part-Time Employees 0 0 0 0
NLNK News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

NLNK NewLink Genetics Corp

Chart of NLNK

Analysts Ratings for NLNK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET NLNK ANALYST REPORT

NLNK Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs